SCHEMBL6446767

SCHEMBL6446767

CC[C@H]1[C@H](C=O)[C@H]1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPM1B O75688 2/20 0.32
PTPN1 P18031 2/20 0.32
PPP1CC P36873 2/20 0.32
GRM2 Q14416 1/20 0.31
GRM3 Q14832 1/20 0.31
GRM8 O00222 1/20 0.31
POLB P06746 1/20 0.31
CTDSP1 Q9GZU7 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
KDM4E B2RXH2 1/20 0.30
GMNN O75496 1/20 0.30
LMNA P02545 1/20 0.30
PMP22 Q01453 1/20 0.30
TFPI2 P48307 1/20 0.30
TP53 P04637 1/20 0.30
TSHR P16473 1/20 0.30
NFKB1 P19838 1/20 0.30
THPO P40225 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6446766 1.00 PPM1B (0.32) PPM1BPTPN1PPP1CCGRM2GRM3
SCHEMBL6447097 0.83 KAT2A (0.33) PPM1BPTPN1PPP1CCGRM8
SCHEMBL6447098 0.83 KAT2A (0.33) PPM1BPTPN1PPP1CCGRM8
SCHEMBL31124089 0.75 POLB (0.39) PPM1BPTPN1PPP1CCGRM2GRM3
SCHEMBL32677595 0.75 POLB (0.39) PPM1BPTPN1PPP1CCGRM2GRM3
SCHEMBL12763447 0.72 POLB (0.38) PPM1BPTPN1PPP1CCGRM2GRM3
SCHEMBL11761139 0.72 SUCNR1 (0.35) GRM2GRM3GRM8POLBCTDSP1
SCHEMBL12094374 0.72 SUCNR1 (0.35) GRM2GRM3GRM8POLBCTDSP1
SCHEMBL20143298 0.72 SUCNR1 (0.35) GRM2GRM3GRM8POLBCTDSP1
SCHEMBL7143232 0.71 GRM2 (0.42) GRM2GRM3GRM8POLBCTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1189874-B1 EXCITATORY AMINO ACID RECEPTOR MODULATORS LILLY SA (ES) 2005-01-26 EP disclosed
US-6504052-B1 2-carboxycyclopropyl glycine derivatives, used as agonists of glutamate receptors for prophylaxis of psychological and nervous system disorders; anxiolytics; antidepressants; drug abuse; anticonvulsant, analgesic and antiemetic agents ELI LILLY AND COMPANY 2003-01-07 US disclosed